X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.320
-0.080 (-2.35%)
At close: Sep 11, 2026, 4:00 PM EDT
3.500
+0.180 (5.42%)
After-hours: Sep 11, 2026, 4:10 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $329.17 million as of September 11, 2026. Its market cap has increased by 332.52% in one year.
Market Cap
329.17M
Enterprise Value
198.42M
1-Year Change
332.52%
Ranking
Category
Stock Price
$3.32
ChartMarket Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $329.17M, an increase of 223.43%. That is a compound annual growth rate of 16.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 329.17M | -5.88% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 361.07M |
| DiaMedica Therapeutics | 352.67M |
| Q32 Bio | 348.01M |
| Upstream Bio | 339.03M |
| Vicore Pharma Holding AB | 335.45M |
| Abeona Therapeutics | 334.53M |
| Agenus | 334.50M |
| Lyell Immunopharma | 331.55M |